Surface plasmon resonance market growth is anticipated during the forecast period due to key market players applying surface plasmon resonance more frequently. Surface plasmon resonance has a significant influence on the development and discovery of new drugs. It is well recognised that finding and developing small molecule drugs is an expensive, time-consuming, and unsuccessful enterprise. For target identification and ligand fishing in proteomics, target assay validation for High Throughput Screening (HTS), quick affinity ranking, and comprehensive kinetics of interaction for small compounds binding to target proteins, surface plasmon resonance is commonly utilised.
The global market for Surface Plasmon Resonance is anticipated to reach US$ 976.1 million in 2023 and is predicted to grow at a 6.5% CAGR from 2023 to 2030.
Leading Companies in the Surface Plasmon Resonance Industry:
1. Bio-Rad Laboratories, Inc,: Built in 1952. With its headquarters in Hercules, California, Bio-Rad Laboratories creates, produces, and sells goods and services for the clinical diagnostics and life sciences industries. Bio-Rad produces, markets, and maintains test systems and specialised quality controls for clinical laboratories in the diagnostics sector (53% of revenue). The company creates and produces a variety of tools and reagents for use in research, the production of biopharmaceuticals, and food testing in the life sciences sector (47% of revenue). Major markets for the corporation are found in the Americas, Europe, Africa, and Asia-Pacific. Sartorius AG, a supplier of lab supplies and biopharmaceuticals, is 37% owned by Bio-Rad. Acquisition of Curiosity Diagnostics by Bio-Rad
2. Carterra Inc.: Established in 2005. Headquarters in the United States. Owner of a biosensor platform designed to hasten the identification of fresh therapeutic prospects. By combining patented microfluidic technology, real-time high throughput surface plasmon resonance (HT-SPR), kinetic and epitope analysis, and visualisation software, the company's monoclonal antibody (mAb) characterization platform enables pharmaceutical and biotechnology clients to thoroughly and quickly screen antibodies and discover potential novel therapeutic candidates. To significantly improve its antibody screening capabilities in the search for novel therapeutic and diagnostic antibodies, Icosagen purchases the Carterra LSA instrument.
3. AMETEK, Inc.: Established in 1930. Headquarters in the United States. Ametek is a multifaceted industrial group with annual revenues of approximately $6 billion. An electrical instruments group and an electromechanical group run the business. For the process, aerospace, power, and industrial end sectors, EIG designs and produces unique and cutting-edge equipment. EMG is a specialised, specialised producer of items like electrical interconnects, speciality metals, thermal management systems, and highly developed automation solutions. The United States accounts for about half of the company's sales. Magnetrol International, Crank Software, and EGS Automation (EGS) were the three acquisitions that AMETEK, Inc. (NYSE: AME) announced it had completed in 2021. These acquisitions cost about $270 million, and their combined yearly sales total about $120 million.
4. Bristol Myers Squibb: Founded in 1887. United States headquarters. Bristol-Myers Squibb finds, creates, and sells medications for a range of therapeutic areas, including immunological, cancer, and cardiovascular illnesses. Bristol is a leader in drug discovery and has immuno-oncology as one of its main areas of concentration. Bristol is more dependent on the American market than the majority of its peer group, with close to 70% of its entire revenues coming from this country. Turning Point Therapeutics, a Prominent Precision Oncology Company, was acquired by Bristol Myers Squibb.
5. Horiba, Ltd.: Established in 1946. Located in England, in the United Kingdom. a company that offers engineering, testing, and development research services for the automobile, railroad, aerospace, and other industries. HORIBA Europe declares the purchase of BeXema
6. Bruker: Founded in 1960. United States headquarters. For clients in the biotechnology, pharmaceutical, and life sciences sectors, Bruker Corp. produces diagnostic tests and scientific instruments. Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST) are its four operating segments. The BSI CALID division brings in the most money for the business. Geographically, Europe is where the company gets the majority of its income. Zontal (May 2023) and Biognosys (Jan 2023) are the most recent acquisitions.
7. Biosensing Instrument Inc: Established in 2004. Arizona's headquarters. Located in Tempe, Arizona, Biosensing Instrument, Inc. (BI) is a privately held business that leads the way in label-free molecular interaction analysis applications. The Surface Plasmon Resonance (SPR) technology underpinning BI solutions is utilised in academia and biopharmaceutical research to quantify the affinities and kinetics of small compounds or biologics. Application fields include biosensors, electrochemistry, drug discovery, antibody characterisation, and life sciences.
*Definition: Surface plasmon resonance (SPR) is the collective oscillation of conduction band electrons that are in resonance with the oscillating electric field of incident light, which will produce energetic plasmonic electrons through non-radiative excitation.
